Example: Heart Attack

Search clinical trials for: Orlistat

Total 63 results

NCT02706067

Completed

Multifactorial Approach Associated With Orlistat (Xenical) for 4 Years Weight Loss Maintenance in Obese Adults

Conditions: Obesity
NCT02767531

Active, not recruiting

Orlistat for the Treatment of Type I Hyperlipoproteinemia

Conditions: Hyperlipoproteinemia Type I; Hypertriglyceridemia
NCT01170806

Completed

Study of Fat Malabsorption by Lipiblock Versus Xenical

Conditions: Obesity
NCT01003483

Completed

Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients

Conditions: Obesity
NCT01332448

Completed

Meta-analysis of Orlistat Laboratory Data From Placebo-controlled Clinical Trials

Conditions: Obesity
NCT01414465

Completed

Orlistat Induced Modulation on the Fatty Acid Composition in Obese Females

Conditions: Overweight
NCT00601354

Completed

Adding Guided Self-Help Group Therapy to the Alli Weight Loss Program in Treating Binge Eating Disorder

Conditions: Overweight; Eating Disorders
NCT01035333

Completed

A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery.

Conditions: Obesity
NCT00752726

Completed

Effect of Orlistat in Body Composition

Conditions: Obesity; Overweight
NCT03675191

Completed

Orlistat/Phentermine Versus Placebo/Phentermine

Conditions: Obesity; Overweight
NCT01719419

Withdrawn

The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects

Conditions: Overweight
NCT02529631

Completed

RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity

Conditions: Overweight; Obesity
NCT01184560

Completed

Assess the Additional Weight Loss Effect of Orlistat Used in Combination With Sibutramine

Conditions: Obesity
NCT01387243

Completed

Survey on the Pharmacy Follow-up of Alli Purchasers

Conditions: Overweight
NCT00108524

Completed

A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss

Conditions: Diabetes Mellitus; Obesity
NCT00991926

Completed

Growth Factor/Insulin-like Growth Factor (GH/IGF)-1 Axis in Obese Subjects in Treatment With Orlistat

Conditions: Obesity
NCT01550926

Completed

A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms

Conditions: Overweight
NCT01126970

Completed

Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects

Conditions: Obesity
NCT03884127

Unknown status

Ezetimibe and Orlistat Affect the Intestinal Flora of Hyperlipidemia.

Conditions: Hyperlipidemia
NCT00001723

Completed

Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases

Conditions: Diabetes Mellitus; Hypertension; Metabolic Disease; Obesity; Sleep Apnea Syndrome
NCT00152360

Completed

The Effect of Xenical on Weight and Risk Factors

Conditions: Obesity; Heart Diseases
NCT00461799

Completed

Orlistat Treatment of Crigler-Najjar Disease

Conditions: Crigler-Najjar Syndrome
NCT01755676

Completed

Evaluation of Orlistat as Adjuvant Treatment of Obesity in Adults

Conditions: Obesity
NCT00207311

Completed

Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus

Conditions: Fatty Liver; Hepatitis C
NCT00292799

Completed

An RCT of Metformin Vs Orlistat in Obese Anovulatory Women

Conditions: Anovulation; Obesity